Look for:

PHARMA MAR SA


ISIN:
ES0169501022
WKN:
-
2024/03/25 19:46:36
Price
29.29 USD
Difference -3.58% (-1.09)

General attributes

ISINES0169501022
SymbolPHM
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)528 EUR
BenchmarkIBEX 35

Market data

Bid (Bid size)-
Ask (Ask size)-
Open29.29 USD
High29.29 USD
Low29.29 USD
Close (prev. day)30.378 USD
VWAP29.29 USD
Volume (pcs)125
Trading volume3,661.25
Number of trades1
Last size125

Futures and Options

Related Futures-
Related Options1,071
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/25 19:46:36
Price
29.29 USD
Difference -3.58% (-1.09)

General attributes

ISINES0169501022
SymbolPHM
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)528 EUR
BenchmarkIBEX 35

Market data

Bid (Bid size)-
Ask (Ask size)-
Open29.29 USD
High29.29 USD
Low29.29 USD
Close (prev. day)30.378 USD
VWAP29.29 USD
Volume (pcs)125
Trading volume3,661.25
Number of trades1
Last size125

Performance and Risk

6m1y3y
Perf (%)--38.60%-75.02%
Perf (abs.)--18.41-87.96
Beta0.870.890.67
Volatility24.4541.3531.59
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)29.29 USD (26)
Ø price 30 days | Ø volume 30 days (pcs.)32.15 USD (139)
Ø price 100 days | Ø volume 100 days (pcs.)36.20 USD (107)
Ø price 250 days | Ø volume 250 days (pcs.)37.49 USD (81)
YTD High | date44.13 USD (2024/01/24)
YTD Low | date29.29 USD (2024/03/25)
52 Weeks High | date47.11 USD (2023/04/03)
52 Weeks Low | date29.29 USD (2024/03/25)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
BME Continuous Market2024/03/2817:3528.74 EUR1.07438
Berlin2024/03/2817:5528.74 EUR0.0013
Duesseldorf2024/03/2816:3128.76 EUR0.004
FINRA other OTC Issues2024/03/2519:4629.29 USD0.001
Frankfurt2024/03/2808:1128.30 EUR0.001
London Stock Exchange European Trade Reporting2024/03/2817:3028.63 EUR0.002
Munich2024/03/2808:1628.30 EUR0.001
Stuttgart2024/03/2817:2028.74 EUR0.009
Tradegate2024/03/2722:2628.44 EUR0.002
Vienna Stock Exchange2024/03/2709:0528.34 EUR0.003

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=140564&ID_TYPE_IMAGE_LOGO=2

Contact Details

PHARMA MAR SA
- -
Avenida de los Reyes, 1, Polígono Industrial La Mina - 28770 Colmenar Viejo
Telefon: +34-91-846-60-00
Fax: +34-91-846-60-01
E-mail: pharmamar@pharmamar.com

Company Profile

-

Members of Management Board

José María Fernández Sousa-FaroChairman of Managing Board
José Luis Moreno Martinez-LosaMember of Executive Committee
José Luis Ortega ConejeroMember of Executive Committee
Juan Carlos Villalón GomezMember of Executive Committee
Juan Gómez PulidoMember of Executive Committee
Luis Mora CapitánMember of Executive Committee
María Concepción SanzMember of Executive Committee
María Luisa de Francia CaballeroMember of Executive Committee
Sandra Llamera SánchezMember of Executive Committee

Board of directors

Montserrat Andrade DetrellMember of Supervisory Board
Blanca Hernández RodríguezMember of Supervisory Board
Carlos PazosMember of Supervisory Board
Carlos Solchaga CatalánMember of Supervisory Board
Eduardo Serra RexachMember of Supervisory Board
Emiliano Calvo AllerMember of Supervisory Board
Mariano Esteban RodríguezMember of Supervisory Board
Martín-Delgado FernandoMember of Supervisory Board
Pedro Fernández PuentesMember of Supervisory Board
Rosa María Sánchez-Yebra AlonsoMember of Supervisory Board
Sandra Ortega MeraMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.